ペプチド化粧品用APIの世界市場：供給源・用途・エンドユーザー産業・地域別 (～2035年)

世界のペプチド化粧品用APIの市場規模は、2024年の9億2,130万米ドルから、CAGR11.2％で推移し、2035年には29億6,840万米ドルに成長すると予測されてます。

世界のペプチド化粧品用API市場は、自然でオーガニックな美容ソリューションに対する消費者需要の高まりに大きく後押しされ、力強い成長を遂げています。皮膚の安全性と持続可能性への意識が高まるにつれて、クリーンな美容基準に沿ったペプチドベースの製品に注目が集まっています。ペプチド合成の急速な技術進歩は、より安定的で効果的な化粧品処方の創出を可能にしました。さらに、個別の肌悩みに対応したパーソナライズドスキンケアへのニーズの高まりも、カスタマイズ可能なペプチドの活用を後押ししています。皮膚科学研究の進展により、スキンケアにおけるペプチドの有効性が次々と科学的に証明されており、市場での採用がさらに進んでいます。

とはいえ、市場にはいくつかの障壁があります。合成や製剤化のコストが高いこと、製品の安定性や送達メカニズムに課題があること、製品承認を遅らせる可能性のある複雑な規制プロセスなどです。また、代替有効成分との競合も制約となります。

こうした課題にもかかわらず、特にバイオエンジニアリングされたペプチド、AIを活用したスキンケア、男性に特化したアンチエイジング製品、マルチステップスキンケアルーティン、ペプチド研究の革新といった分野では成長の見込みは依然として強いです。

地域分析

世界のペプチド化粧品用API市場においては、北米がリードしています。これは、機能性やアンチエイジング効果への強い関心、広く浸透した消費者の認知、確立されたスキンケアブランドの存在によるものです。さらに、高度な研究基盤と、科学的根拠に基づく高級製品を好む傾向が、成長を後押ししています。

欧州もまた、重要な市場の一つです。クリーンビューティーへの需要や、厳格な成分規制、ドイツ、フランス、イギリスにおけるアンチエイジング市場の活況が、市場成長を支えています。

アジア太平洋地域では、KビューティーやJビューティーの影響、急速な都市化、多機能スキンケアを好む若年層の存在が、中国、日本、韓国などでの急成長を促進しています。

当レポートでは、世界のペプチド化粧品用APIの市場を調査し、市場の定義と概要、市場成長への各種影響因子の分析、市場規模の推移・予測、各種区分・地域/主要国別の内訳、競合環境、主要企業のプロファイルなどをまとめています。

目次

第1章 エグゼクティブサマリー

第2章 市場概要

第3章 調査手法

第4章 市場力学

• 促進要因
  • 自然・オーガニック化粧品の需要増加
  • ペプチド合成における技術的進歩
  • パーソナライズされたスキンケアソリューションへの関心の高まり
  • 皮膚科におけるペプチドの効能に関する研究の拡大
• 抑制要因
  • ペプチド合成と製剤化の高コスト
  • 安定性と配送の課題
  • 規制の複雑さと承認の遅延
  • 代替有効成分との競合
• 機会
  • クリーンビューティーにおけるバイオエンジニアリングペプチド
  • AI駆動型パーソナライズスキンケア
  • マルチステップスキンケアにおけるペプチド
  • メンズグルーミングとアンチエイジングソリューション
  • ペプチド研究における革新
• COVID-19の影響分析

第5章 市場要因分析

• サプライチェーン分析
• ポーターのファイブフォースモデル

第6章 ペプチド化粧品用API市場：用途別

• アンチエイジングとシワの軽減
• 肌の修復と再生
• 保湿と水分補給
• ホワイトニング＆ブライトニング
• ヘアケア
• 抗炎症作用と鎮静作用

第7章 ペプチド化粧品用API市場：供給元別

• 植物由来ペプチド
• 動物由来ペプチド
• バイオエンジニアリングペプチド
• 化学合成

第8章 ペプチド化粧品用API市場：エンドユーザー産業別

• スキンケア
• ヘアケア
• 注入型化粧品
• その他

第9章 ペプチド化粧品用API市場：地域別

• 概要
• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • ロシア
  • イタリア
  • スペイン
  • その他
• アジア太平洋
  • 中国
  • インド
  • 日本
  • 韓国
  • マレーシア
  • タイ
  • インドネシア
  • その他
• 南米
  • ブラジル
  • メキシコ
  • アルゼンチン
  • その他
• MEA
  • GCC諸国
  • 南アフリカ
  • その他

第10章 競合情勢

• 市場シェア分析
• 競合ダッシュボード

第11章 企業プロファイル

• DSM-FIRMENICH
• BACHEM
• LIPOTRUE SCIENCE
• CRODA
• CAREGEN
• BASF SE
• EVONIK INDUSTRIES AG
• GIVAUDAN ACTIVE BEAUTY
• ASHLAND GLOBAL HOLDINGS
• SYMRISE AG
• PROVITAL GROUP
• SPEC-CHEM INDUSTRY INC
• AMBIOPHARM
• LIPOTEC
• USV PRIVATE LIMITED
• CHEMISCHES LABORATORIUM DR. KURT RICHTER GMBH（CLR）
• ACTIVE PEPTIDE COMPANY
• SEIWA KASEI CO., LTD
• RS SYNTHESIS
• BCN PEPTIDES

LIST OF TABLES

• TABLE 1 PEPTIDE COSMETIC API MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
• TABLE 2 PEPTIDE COSMETIC API MARKET, SOURCE, 2019-2035 (USD MILLION)
• TABLE 3 PEPTIDE COSMETIC API MARKET, BY END-USE INDUSTRY, 2019-2035 (USD MILLION)
• TABLE 4 PEPTIDE COSMETIC API MARKET, BY REGION, 2019-2035 (USD MILLION)
• TABLE 5 PEPTIDE COSMETIC API MARKET, FOR NORTH AMERICA, BY COUNTRY, 2019-2035 (USD MILLION)
• TABLE 6 PEPTIDE COSMETIC API MARKET, FOR NORTH AMERICA, BY APPLICATION, 2019-2035 (USD MILLION)
• TABLE 7 PEPTIDE COSMETIC API MARKET, FOR NORTH AMERICA, BY SOURCE, 2019-2035 (USD MILLION)
• TABLE 8 PEPTIDE COSMETIC API MARKET, FOR NORTH AMERICA, BY END-USE INDUSTRY, 2019-2035 (USD MILLION)
• TABLE 9 US: PEPTIDE COSMETIC API MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
• TABLE 10 US: PEPTIDE COSMETIC API MARKET, BY SOURCE, 2019-2035 (USD MILLION)
• TABLE 11 US: PEPTIDE COSMETIC API MARKET, BY END-USE INDUSTRY, 2019-2035 (USD MILLION)
• TABLE 12 CANADA: PEPTIDE COSMETIC API MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
• TABLE 13 CANADA: PEPTIDE COSMETIC API MARKET, BY SOURCE, 2019-2035 (USD MILLION)
• TABLE 14 CANADA: PEPTIDE COSMETIC API MARKET, BY END-USE INDUSTRY, 2019-2035 (USD MILLION)
• TABLE 15 PEPTIDE COSMETIC API MARKET, FOR EUROPE, BY COUNTRY, 2019-2035 (USD MILLION)
• TABLE 16 PEPTIDE COSMETIC API MARKET, FOR EUROPE , BY APPLICATION, 2019-2035 (USD MILLION)
• TABLE 17 PEPTIDE COSMETIC API MARKET, FOR EUROPE, BY SOURCE, 2019-2035 (USD MILLION)
• TABLE 18 PEPTIDE COSMETIC API MARKET, FOR EUROPE , BY END-USE INDUSTRY, 2019-2035 (USD MILLION)
• TABLE 19 GERMANY: PEPTIDE COSMETIC API MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
• TABLE 20 GERMANY: PEPTIDE COSMETIC API MARKET, BY SOURCE, 2019-2035 (USD MILLION)
• TABLE 21 GERMANY: PEPTIDE COSMETIC API MARKET, BY END-USE INDUSTRY, 2019-2035 (USD MILLION)
• TABLE 22 UK: PEPTIDE COSMETIC API MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
• TABLE 23 UK: PEPTIDE COSMETIC API MARKET, BY SOURCE, 2019-2035 (USD MILLION)
• TABLE 24 UK: PEPTIDE COSMETIC API MARKET, BY END-USE INDUSTRY, 2019-2035 (USD MILLION)
• TABLE 25 FRANCE: PEPTIDE COSMETIC API MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
• TABLE 26 FRANCE: PEPTIDE COSMETIC API MARKET, BY SOURCE, 2019-2035 (USD MILLION)
• TABLE 27 FRANCE: PEPTIDE COSMETIC API MARKET, BY END-USE INDUSTRY, 2019-2035 (USD MILLION)
• TABLE 28 RUSSIA: PEPTIDE COSMETIC API MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
• TABLE 29 RUSSIA: PEPTIDE COSMETIC API MARKET, BY SOURCE, 2019-2035 (USD MILLION)
• TABLE 30 RUSSIA: PEPTIDE COSMETIC API MARKET, BY END-USE INDUSTRY, 2019-2035 (USD MILLION)
• TABLE 31 ITALY: PEPTIDE COSMETIC API MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
• TABLE 32 ITALY: PEPTIDE COSMETIC API MARKET, BY SOURCE, 2019-2035 (USD MILLION)
• TABLE 33 ITALY: PEPTIDE COSMETIC API MARKET, BY END-USE INDUSTRY, 2019-2035 (USD MILLION)
• TABLE 34 SPAIN: PEPTIDE COSMETIC API MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
• TABLE 35 SPAIN: PEPTIDE COSMETIC API MARKET, BY SOURCE, 2019-2035 (USD MILLION)
• TABLE 36 SPAIN: PEPTIDE COSMETIC API MARKET, BY END-USE INDUSTRY, 2019-2035 (USD MILLION)
• TABLE 37 REST OF EUROPE: PEPTIDE COSMETIC API MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
• TABLE 38 REST OF EUROPE: PEPTIDE COSMETIC API MARKET, BY SOURCE, 2019-2035 (USD MILLION)
• TABLE 39 REST OF EUROPE: PEPTIDE COSMETIC API MARKET, BY END-USE INDUSTRY, 2019-2035 (USD MILLION)
• TABLE 40 PEPTIDE COSMETIC API MARKET, FOR APAC , BY COUNTRY, 2019-2035 (USD MILLION)
• TABLE 41 PEPTIDE COSMETIC API MARKET, FOR APAC , BY APPLICATION, 2019-2035 (USD MILLION)
• TABLE 42 PEPTIDE COSMETIC API MARKET, FOR APAC , BY SOURCE, 2019-2035 (USD MILLION)
• TABLE 43 PEPTIDE COSMETIC API MARKET, FOR APAC , BY END-USE INDUSTRY, 2019-2035 (USD MILLION)
• TABLE 44 CHINA: PEPTIDE COSMETIC API MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
• TABLE 45 CHINA: PEPTIDE COSMETIC API MARKET, BY SOURCE, 2019-2035 (USD MILLION)
• TABLE 46 CHINA: PEPTIDE COSMETIC API MARKET, BY END-USE INDUSTRY, 2019-2035 (USD MILLION)
• TABLE 47 INDIA: PEPTIDE COSMETIC API MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
• TABLE 48 INDIA: PEPTIDE COSMETIC API MARKET, BY SOURCE, 2019-2035 (USD MILLION)
• TABLE 49 INDIA: PEPTIDE COSMETIC API MARKET, BY END-USE INDUSTRY, 2019-2035 (USD MILLION)
• TABLE 50 JAPAN: PEPTIDE COSMETIC API MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
• TABLE 51 JAPAN: PEPTIDE COSMETIC API MARKET, BY SOURCE, 2019-2035 (USD MILLION)
• TABLE 52 JAPAN: PEPTIDE COSMETIC API MARKET, BY END-USE INDUSTRY, 2019-2035 (USD MILLION)
• TABLE 53 SOUTH KOREA: PEPTIDE COSMETIC API MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
• TABLE 54 SOUTH KOREA: PEPTIDE COSMETIC API MARKET, BY SOURCE, 2019-2035 (USD MILLION)
• TABLE 55 SOUTH KOREA: PEPTIDE COSMETIC API MARKET, BY END-USE INDUSTRY, 2019-2035 (USD MILLION)
• TABLE 56 MALAYSIA: PEPTIDE COSMETIC API MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
• TABLE 57 MALAYSIA: PEPTIDE COSMETIC API MARKET, BY SOURCE, 2019-2035 (USD MILLION)
• TABLE 58 MALAYSIA: PEPTIDE COSMETIC API MARKET, BY END-USE INDUSTRY, 2019-2035 (USD MILLION)
• TABLE 59 THAILAND: PEPTIDE COSMETIC API MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
• TABLE 60 THAILAND: PEPTIDE COSMETIC API MARKET, BY SOURCE, 2019-2035 (USD MILLION)
• TABLE 61 THAILAND: PEPTIDE COSMETIC API MARKET, BY END-USE INDUSTRY, 2019-2035 (USD MILLION)
• TABLE 62 INDONESIA: PEPTIDE COSMETIC API MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
• TABLE 63 INDONESIA: PEPTIDE COSMETIC API MARKET, BY SOURCE, 2019-2035 (USD MILLION)
• TABLE 64 INDONESIA: PEPTIDE COSMETIC API MARKET, BY END-USE INDUSTRY, 2019-2035 (USD MILLION)
• TABLE 65 REST OF APAC: PEPTIDE COSMETIC API MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
• TABLE 66 REST OF APAC: PEPTIDE COSMETIC API MARKET, BY SOURCE, 2019-2035 (USD MILLION)
• TABLE 67 REST OF APAC: PEPTIDE COSMETIC API MARKET, BY END-USE INDUSTRY, 2019-2035 (USD MILLION)
• TABLE 68 PEPTIDE COSMETIC API MARKET, FOR SOUTH AMERICA , BY COUNTRY, 2019-2035 (USD MILLION)
• TABLE 69 PEPTIDE COSMETIC API MARKET, FOR SOUTH AMERICA , BY APPLICATION, 2019-2035 (USD MILLION)
• TABLE 70 PEPTIDE COSMETIC API MARKET, FOR SOUTH AMERICA , BY SOURCE, 2019-2035 (USD MILLION)
• TABLE 71 PEPTIDE COSMETIC API MARKET, FOR SOUTH AMERICA , BY END-USE INDUSTRY, 2019-2035 (USD MILLION)
• TABLE 72 BRAZIL: PEPTIDE COSMETIC API MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
• TABLE 73 BRAZIL: PEPTIDE COSMETIC API MARKET, BY SOURCE, 2019-2035 (USD MILLION)
• TABLE 74 BRAZIL: PEPTIDE COSMETIC API MARKET, BY END-USE INDUSTRY, 2019-2035 (USD MILLION)
• TABLE 75 MEXICO: PEPTIDE COSMETIC API MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
• TABLE 76 MEXICO: PEPTIDE COSMETIC API MARKET, BY SOURCE, 2019-2035 (USD MILLION)
• TABLE 77 MEXICO: PEPTIDE COSMETIC API MARKET, BY END-USE INDUSTRY, 2019-2035 (USD MILLION)
• TABLE 78 ARGENTINA: PEPTIDE COSMETIC API MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
• TABLE 79 ARGENTINA: PEPTIDE COSMETIC API MARKET, BY SOURCE, 2019-2035 (USD MILLION)
• TABLE 80 ARGENTINA: PEPTIDE COSMETIC API MARKET, BY END-USE INDUSTRY, 2019-2035 (USD MILLION)
• TABLE 81 REST OF SOUTH AMERICA: PEPTIDE COSMETIC API MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
• TABLE 82 REST OF SOUTH AMERICA: PEPTIDE COSMETIC API MARKET, BY SOURCE, 2019-2035 (USD MILLION)
• TABLE 83 REST OF SOUTH AMERICA: PEPTIDE COSMETIC API MARKET, BY END-USE INDUSTRY, 2019-2035 (USD MILLION)
• TABLE 84 PEPTIDE COSMETIC API MARKET, FOR MEA, BY COUNTRY, 2019-2035 (USD MILLION)
• TABLE 85 PEPTIDE COSMETIC API MARKET, FOR MEA, BY APPLICATION, 2019-2035 (USD MILLION)
• TABLE 86 PEPTIDE COSMETIC API MARKET, FOR MEA, BY SOURCE, 2019-2035 (USD MILLION)
• TABLE 87 PEPTIDE COSMETIC API MARKET, FOR MEA, BY END-USE INDUSTRY, 2019-2035 (USD MILLION)
• TABLE 88 GCC COUNTRIES: PEPTIDE COSMETIC API MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
• TABLE 89 GCC COUNTRIES: PEPTIDE COSMETIC API MARKET, BY SOURCE, 2019-2035 (USD MILLION)
• TABLE 90 GCC COUNTRIES: PEPTIDE COSMETIC API MARKET, BY END-USE INDUSTRY, 2019-2035 (USD MILLION)
• TABLE 91 SOUTH AFRICA: PEPTIDE COSMETIC API MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
• TABLE 92 SOUTH AFRICA: PEPTIDE COSMETIC API MARKET, BY SOURCE, 2019-2035 (USD MILLION)
• TABLE 93 SOUTH AFRICA: PEPTIDE COSMETIC API MARKET, BY END-USE INDUSTRY, 2019-2035 (USD MILLION)
• TABLE 94 REST OF MEA: PEPTIDE COSMETIC API MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
• TABLE 95 REST OF MEA: PEPTIDE COSMETIC API MARKET, BY SOURCE, 2019-2035 (USD MILLION)
• TABLE 96 REST OF MEA: PEPTIDE COSMETIC API MARKET, BY END-USE INDUSTRY, 2019-2035 (USD MILLION)
• TABLE 97 DSM-FIRMENICH: PRODUCT OFFERED
• TABLE 98 BACHEM: PRODUCT OFFERED
• TABLE 99 LIPOTRUE SCIENCE: PRODUCT OFFERED
• TABLE 100 CRODA: PRODUCT OFFERED
• TABLE 101 CAREGEN: PRODUCT OFFERED
• TABLE 102 BASF SE: PRODUCT OFFERED
• TABLE 103 EVONIK INDUSTRIES AG: PRODUCT OFFERED
• TABLE 104 GIVAUDAN ACTIVE BEAUTY: PRODUCT OFFERED
• TABLE 105 ASHLAND GLOBAL HOLDINGS: PRODUCT OFFERED
• TABLE 106 SYMRISE AG: PRODUCT OFFERED
• TABLE 107 PROVITAL GROUP: PRODUCT OFFERED
• TABLE 108 SPEC-CHEM INDUSTRY INC: PRODUCT OFFERED
• TABLE 109 AMBIOPHARM: PRODUCT OFFERED
• TABLE 110 LIPOTEC: PRODUCT OFFERED
• TABLE 111 USV PRIVATE LIMITED: PRODUCT OFFERED
• TABLE 112 CHEMISCHES LABORATORIUM DR. KURT RICHTER GMBH (CLR): PRODUCT OFFERED
• TABLE 113 ACTIVE PEPTIDE COMPANY: PRODUCT OFFERED
• TABLE 114 SEIWA KASEI CO., LTD: PRODUCT OFFERED
• TABLE 115 RS SYNTHESIS: PRODUCT OFFERED
• TABLE 116 BCN PEPTIDES: PRODUCT OFFERED

LIST OF FIGURES

• FIGURE 1 PEPTIDE COSMETIC API MARKET: MARKET GROWTH FACTOR ANALYSIS (2019-2035)
• FIGURE 3 SUPPLY CHAIN ANALYSIS: PEPTIDE COSMETIC API MARKET
• FIGURE 5 PORTER'S FIVE FORCES MODEL: PEPTIDE COSMETIC API MARKET
• FIGURE 6 PEPTIDE COSMETIC API MARKET, BY APPLICATION, 2023 (% SHARE)
• FIGURE 7 PEPTIDE COSMETIC API MARKET, BY SOURCE, 2023 (% SHARE)
• FIGURE 8 PEPTIDE COSMETIC API MARKET, BY END-USE INDUSTRY, 2023 (% SHARE)
• FIGURE 9 GLOBAL PEPTIDE COSMETIC API MARKET PLAYERS: COMPETITIVE ANALSIS, 2023
• FIGURE 10 INDUSTRY CONCENTRATION, 2024
• FIGURE 11 COMPETITOR DASHBOARD: GLOBAL MILITARY DRIVER VISION ENHANCER
• FIGURE 12 DSM-FIRMENICH: FINANCIAL OVERVIEW SNAPSHOT
• FIGURE 13 DSM-FIRMENICH: SWOT ANALYSIS
• FIGURE 14 BACHEM: FINANCIAL OVERVIEW SNAPSHOT
• FIGURE 15 BACHEM: SWOT ANALYSIS
• FIGURE 16 LIPOTRUE SCIENCE: SWOT ANALYSIS
• FIGURE 17 CRODA: FINANCIAL OVERVIEW SNAPSHOT
• FIGURE 18 CRODA: SWOT ANALYSIS
• FIGURE 19 CAREGEN: SWOT ANALYSIS
• FIGURE 20 BASF SE: FINANCIAL OVERVIEW SNAPSHOT
• FIGURE 21 BASF SE: SWOT ANALYSIS
• FIGURE 22 EVONIK: FINANCIAL OVERVIEW SNAPSHOT
• FIGURE 23 EVONIK INDUSTRIES AG: SWOT ANALYSIS
• FIGURE 24 GIVAUDAN ACTIVE BEAUTY: FINANCIAL OVERVIEW SNAPSHOT
• FIGURE 25 GIVAUDAN ACTIVE BEAUTY: SWOT ANALYSIS
• FIGURE 26 ASHLAND GLOBAL HOLDINGS: FINANCIAL OVERVIEW SNAPSHOT
• FIGURE 27 ASHLAND GLOBAL HOLDINGS: SWOT ANALYSIS
• FIGURE 28 SYMRISE AG: FINANCIAL OVERVIEW SNAPSHOT
• FIGURE 29 SYMRISE AG: SWOT ANALYSIS
• FIGURE 30 PROVITAL GROUP: SWOT ANALYSIS
• FIGURE 31 SPEC-CHEM INDUSTRY INC: SWOT ANALYSIS
• FIGURE 32 AMBIOPHARM: SWOT ANALYSIS
• FIGURE 33 LIPOTEC: SWOT ANALYSIS
• FIGURE 34 USV PRIVATE LIMITED: SWOT ANALYSIS
• FIGURE 35 CHEMISCHES LABORATORIUM DR. KURT RICHTER GMBH (CLR): SWOT ANALYSIS
• FIGURE 36 ACTIVE PEPTIDE COMPANY: SWOT ANALYSIS
• FIGURE 37 SEIWA KASEI CO., LTD: SWOT ANALYSIS
• FIGURE 38 RS SYNTHESIS: SWOT ANALYSIS
• FIGURE 39 BCN PEPTIDES: SWOT ANALYSIS

Global Peptide Cosmetic API Research Report by Source (Plant-Derived Peptides, Animal-Derived Peptides, Bioengineered Peptides, Chemically Synthesized), by Application (Anti-Aging & Wrinkle Reduction, Skin Repair & Regeneration, Moisturizing & Hydration, Whitening & Brightening, Hair Care, Anti-Inflammatory & Soothing), by End-Use Industry (Skincare, Haircare, Injectable Cosmetics, Others), by Region (North America, Europe, APAC, South America, MEA) Market Forecast till 2035

Industry Overview

The global peptide cosmetic API market is expected to achieve from its 2024 estimate of USD 921.3 million to USD 2,968.4 million by 2035 at a compound annual growth rate (CAGR) of 11.2%.

Global peptide cosmetic API market is witnessing robust growth, largely fueled by increasing consumer demand for natural and organic beauty solutions. As people become more conscious of skin safety and sustainability, they are turning to peptide-based products that align with clean beauty standards. Rapid technological progress in peptide synthesis has enabled the creation of more stable and effective cosmetic formulations. Moreover, the rising inclination toward personalized skincare regimens has boosted the use of peptides, which can be customized for targeted skin concerns. Expanding dermatological research continues to validate the efficacy of peptides in skincare, further promoting their market adoption.

Nevertheless, the market does encounter several barriers. These include the high cost of synthesis and formulation, challenges in product stability and delivery mechanisms, and complex regulatory processes that can delay product approvals. Competition from alternative active ingredients also poses limitations.

Despite these challenges, growth prospects remain strong, especially in areas like bioengineered peptides, AI-driven skincare, male-focused anti-aging products, multi-step skincare routines, and peptide research innovations.

Industry Segmentations

Based on the application category, the global market is included anti-aging & wrinkle reduction, skin repair & regeneration, moisturizing & hydration, whitening & brightening, hair care, anti-inflammatory & soothing.

Chemically synthesized, plant-derived, animal-derived, and bioengineered peptides are all included in the global peptide cosmetic API market, which is divided by source type.

In terms of end-use variation, the global market is segmented into Skincare, haircare, injectable cosmetics, and others.

Regional Analysis

The global peptide cosmetic API market sees North America leading, thanks to widespread awareness, established skincare brands, and strong interest in functional, anti-aging solutions. Advanced research infrastructure and preference for premium, science-led products are key growth enablers.

Europe is a significant player as well, shaped by clean beauty demand, robust ingredient regulations, and a thriving anti-aging sector in Germany, France, and the UK.

Asia-Pacific is experiencing rapid growth, influenced by K-beauty and J-beauty, surging urbanization, and a young population inclined toward multifunctional skincare in China, Japan, and South Korea.

Latin America is gaining traction, primarily due to Brazil's expanding market for natural and anti-aging cosmetics.

Meanwhile, growth in the Middle East & Africa remains moderate but promising, supported by increasing disposable income and urban expansion.

Key Players

Key competitors of global peptide cosmetic API research report are Chemisches Laboratorium Dr. Kurt Richter GmbH, DSM-Firmenich, Provital Group, Bachem, Lipotrue Science, Croda, Caregen, BASF SE, Evonik Industries AG, Givaudan Active Beauty, Ashland Global Holdings, Symrise AG, Spec-Chem Industry Inc, Ambiopharm, Lipotec, USV Private Limited, Active Peptide Company, Seiwa Kasei Co. Ltd., RS Synthesis, BCN Peptides.

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

2 MARKET INTRODUCTION

• 2.1 DEFINITION
• 2.2 SCOPE OF THE STUDY
• 2.3 RESEARCH OBJECTIVE
• 2.4 MARKET STRUCTURE

3 RESEARCH METHODOLOGY

• 3.1 OVERVIEW
• 3.2 DATA FLOW
  • 3.2.1 DATA MINING PROCESS
• 3.3 PURCHASED DATABASE:
• 3.4 SECONDARY SOURCES:
  • 3.4.1 SECONDARY RESEARCH DATA FLOW:
• 3.5 PRIMARY RESEARCH:
  • 3.5.1 PRIMARY RESEARCH DATA FLOW:
  • 3.5.2 PRIMARY RESEARCH: NUMBER OF INTERVIEWS CONDUCTED
  • 3.5.3 PRIMARY RESEARCH: REGIONAL COVERAGE
• 3.6 APPROACHES FOR MARKET END USER ESTIMATION:
  • 3.6.1 REVENUE ANALYSIS APPROACH
  • 3.6.2 DATA FORECASTING
  • 3.6.3 DATA FORECASTING TECHNIQUE
• 3.7 DATA MODELING
  • 3.7.1 MICROECONOMIC FACTOR ANALYSIS:
  • 3.7.2 DATA MODELING:
• 3.8 TEAMS AND ANALYST CONTRIBUTION

4 MARKET DYNAMICS

• 4.1 INTRODUCTION
• 4.2 DRIVERS
  • 4.2.1 INCREASING DEMAND FOR NATURAL AND ORGANIC COSMETICS
  • 4.2.2 TECHNOLOGICAL ADVANCEMENTS IN PEPTIDE SYNTHESIS
  • 4.2.3 GROWING PREFERENCE FOR PERSONALIZED SKINCARE SOLUTIONS
  • 4.2.4 EXPANDING RESEARCH ON PEPTIDE BENEFITS IN DERMATOLOGY
• 4.3 RESTRAINTS
  • 4.3.1 HIGH COST OF PEPTIDE SYNTHESIS AND FORMULATION
  • 4.3.2 STABILITY AND DELIVERY CHALLENGES
  • 4.3.3 REGULATORY COMPLEXITIES AND APPROVAL DELAYS
  • 4.3.4 COMPETITION FROM ALTERNATIVE ACTIVE INGREDIENTS
• 4.4 OPPORTUNITY
  • 4.4.1 BIOENGINEERED PEPTIDES IN CLEAN BEAUTY
  • 4.4.2 AI-DRIVEN PERSONALIZED SKINCARE
  • 4.4.3 PEPTIDES IN MULTI-STEP SKINCARE REGIMENS
  • 4.4.4 MEN'S GROOMING AND ANTI-AGING SOLUTIONS
  • 4.4.5 INNOVATIONS IN PEPTIDE RESEARCH
• 4.5 IMPACT ANALYSIS OF COVID - 19
  • 4.5.1 IMPACT 0N OVERALL HEALTHCARE.
  • 4.5.2 ECONOMIC IMPACT.
  • 4.5.3 IMPACT ON GLOBAL PEPTIDE COSMETIC API MARKET MARKET.
  • 4.5.4 IMPACT ON SUPPLY CHAIN OF PEPTIDE COSMETIC API MARKET
  • 4.5.5 PRICE VARIATION OF KEY RAW MATERIALS.
  • 4.5.6 PRODUCTION SHUTDOWN.
  • 4.5.7 CASH FLOW CONSTRAINTS.
  • 4.5.8 IMPACT ON IMPORT/EXPORT.
  • 4.5.9 IMPACT ON MARKET DEMAND OF PEPTIDE COSMETIC API MARKET.
  • 4.5.10 IMPACT DUE TO RESTRICTIONS/LOCKDOWN.
  • 4.5.11 CONSUMER SENTIMENTS.
  • 4.5.12 IMPACT ON PRICING OF PEPTIDE COSMETIC API MARKET.

5 MARKET FACTOR ANALYSIS

• 5.1 SUPPLY CHAIN ANALYSIS
  • 5.1.1 RAW MATERIAL PROCUREMENT
  • 5.1.2 MANUFACTURING & SYNTHESIS
  • 5.1.3 PACKAGING AND STORAGE
  • 5.1.4 DISTRIBUTION & LOGISTICS
  • 5.1.5 END-USERS & CONSUMER DELIVERY
• 5.2 PORTER'S FIVE FORCES MODEL
  • 5.2.1 BARGAINING POWER OF SUPPLIERS
  • 5.2.2 BARGAINING POWER OF BUYERS
  • 5.2.3 THREAT OF NEW ENTRANTS
  • 5.2.4 THREAT OF SUBSTITUTES
  • 5.2.5 INTENSITY OF RIVALRY

6 PEPTIDE COSMETIC API MARKET, BY APPLICATION

• 6.1 INTRODUCTION
• 6.2 ANTI-AGING & WRINKLE REDUCTION
• 6.3 SKIN REPAIR & REGENERATION
• 6.4 MOISTURIZING & HYDRATION
• 6.5 WHITENING & BRIGHTENING
• 6.6 HAIR CARE
• 6.7 ANTI-INFLAMMATORY & SOOTHING

7 PEPTIDE COSMETIC API MARKET, BY SOURCE

• 7.1 INTRODUCTION
• 7.2 PLANT-DERIVED PEPTIDES
• 7.3 ANIMAL-DERIVED PEPTIDES
• 7.4 BIOENGINEERED PEPTIDES
• 7.5 CHEMICALLY SYNTHESIZED

8 PEPTIDE COSMETIC API MARKET, BY END-USE INDUSTRY

• 8.1 INTRODUCTION
• 8.2 SKINCARE
• 8.3 HAIRCARE
• 8.4 INJECTABLE COSMETICS
• 8.5 OTHERS

9 PEPTIDE COSMETIC API MARKET, BY REGION

• 9.1 OVERVIEW
• 9.2 NORTH AMERICA
  • 9.2.1 US
  • 9.2.2 CANADA
• 9.3 EUROPE
  • 9.3.1 GERMANY
  • 9.3.2 UK
  • 9.3.3 FRANCE
  • 9.3.4 RUSSIA
  • 9.3.5 ITALY
  • 9.3.6 SPAIN
  • 9.3.7 REST OF EUROPE
• 9.4 APAC
  • 9.4.1 CHINA
  • 9.4.2 INDIA
  • 9.4.3 JAPAN
  • 9.4.4 SOUTH KOREA
  • 9.4.5 MALAYSIA
  • 9.4.6 THAILAND
  • 9.4.7 INDONESIA
  • 9.4.8 REST OF APAC
• 9.5 SOUTH AMERICA
  • 9.5.1 BRAZIL
  • 9.5.2 MEXICO
  • 9.5.3 ARGENTINA
  • 9.5.4 REST OF SOUTH AMERICA
• 9.6 MEA
  • 9.6.1 GCC COUNTRIES
  • 9.6.2 SOUTH AFRICA
  • 9.6.3 REST OF MEA

10 COMPETITIVE LANDSCAPE

• 10.1 INTRODUCTION
• 10.2 MARKET SHARE ANALYSIS, 2023
• 10.3 COMPETITOR DASHBOARD

11 COMPANY PROFILES

• 11.1 DSM-FIRMENICH
  • 11.1.1 COMPANY OVERVIEW
  • 11.1.2 FINANCIAL OVERVIEW
  • 11.1.3 TYPES OFFERED
  • 11.1.4 PATENT DETAILS
  • 11.1.5 PRODUCTION CAPACITY
  • 11.1.6 SALES VOLUME
  • 11.1.7 PRICING ANALYSIS
  • 11.1.8 SWOT ANALYSIS
  • 11.1.9 KEY STRATEGY
• 11.2 BACHEM
  • 11.2.1 COMPANY OVERVIEW
  • 11.2.2 FINANCIAL OVERVIEW
  • 11.2.3 TYPES OFFERED
  • 11.2.4 PATENT DETAILS
  • 11.2.5 PRODUCTION CAPACITY
  • 11.2.6 SALES VOLUME
  • 11.2.7 PRICING ANALYSIS
  • 11.2.8 SWOT ANALYSIS
  • 11.2.9 KEY STRATEGY
• 11.3 LIPOTRUE SCIENCE
  • 11.3.1 COMPANY OVERVIEW
  • 11.3.2 TYPES OFFERED
  • 11.3.3 PATENT DETAILS
  • 11.3.4 PRODUCTION CAPACITY
  • 11.3.5 SALES VOLUME
  • 11.3.6 PRICING ANALYSIS
  • 11.3.7 SWOT ANALYSIS
  • 11.3.8 KEY STRATEGY
• 11.4 CRODA
  • 11.4.1 COMPANY OVERVIEW
  • 11.4.2 FINANCIAL OVERVIEW
  • 11.4.3 TYPES OFFERED
  • 11.4.4 PATENT DETAILS
  • 11.4.5 PRODUCTION CAPACITY
  • 11.4.6 SALES VOLUME
  • 11.4.7 PRICING ANALYSIS
  • 11.4.8 SWOT ANALYSIS
  • 11.4.9 KEY STRATEGY
• 11.5 CAREGEN
  • 11.5.1 COMPANY OVERVIEW
  • 11.5.2 TYPES OFFERED
  • 11.5.3 PATENT DETAILS
  • 11.5.4 PRODUCTION CAPACITY
  • 11.5.5 SALES VOLUME
  • 11.5.6 PRICING ANALYSIS
  • 11.5.7 SWOT ANALYSIS
  • 11.5.8 KEY STRATEGY
• 11.6 BASF SE
  • 11.6.1 COMPANY OVERVIEW
  • 11.6.2 FINANCIAL OVERVIEW
  • 11.6.3 TYPES OFFERED
  • 11.6.4 PATENT DETAILS
  • 11.6.5 PRODUCTION CAPACITY
  • 11.6.6 SALES VOLUME
  • 11.6.7 PRICING ANALYSIS
  • 11.6.8 SWOT ANALYSIS
  • 11.6.9 KEY STRATEGY
• 11.7 EVONIK INDUSTRIES AG
  • 11.7.1 COMPANY OVERVIEW
  • 11.7.2 FINANCIAL OVERVIEW
  • 11.7.3 TYPES OFFERED
  • 11.7.4 PATENT DETAILS
  • 11.7.5 PRODUCTION CAPACITY
  • 11.7.6 SALES VOLUME
  • 11.7.7 PRICING ANALYSIS
  • 11.7.8 SWOT ANALYSIS
  • 11.7.9 KEY STRATEGY
• 11.8 GIVAUDAN ACTIVE BEAUTY
  • 11.8.1 COMPANY OVERVIEW
  • 11.8.2 FINANCIAL OVERVIEW
  • 11.8.3 TYPES OFFERED
  • 11.8.4 PATENT DETAILS
  • 11.8.5 PRODUCTION CAPACITY
  • 11.8.6 SALES VOLUME
  • 11.8.7 PRICING ANALYSIS
  • 11.8.8 SWOT ANALYSIS
  • 11.8.9 KEY STRATEGY
• 11.9 ASHLAND GLOBAL HOLDINGS
  • 11.9.1 COMPANY OVERVIEW
  • 11.9.2 FINANCIAL OVERVIEW
  • 11.9.3 TYPES OFFERED
  • 11.9.4 PATENT DETAILS
  • 11.9.5 PRODUCTION CAPACITY
  • 11.9.6 SALES VOLUME
  • 11.9.7 PRICING ANALYSIS
  • 11.9.8 SWOT ANALYSIS
  • 11.9.9 KEY STRATEGY
• 11.10 SYMRISE AG
  • 11.10.1 COMPANY OVERVIEW
  • 11.10.2 FINANCIAL OVERVIEW
  • 11.10.3 TYPES OFFERED
  • 11.10.4 PATENT DETAILS
  • 11.10.5 PRODUCTION CAPACITY
  • 11.10.6 SALES VOLUME
  • 11.10.7 PRICING ANALYSIS
  • 11.10.8 SWOT ANALYSIS
  • 11.10.9 KEY STRATEGY
• 11.11 PROVITAL GROUP
  • 11.11.1 COMPANY OVERVIEW
  • 11.11.2 TYPES OFFERED
  • 11.11.3 PATENT DETAILS
  • 11.11.4 PRODUCTION CAPACITY
  • 11.11.5 SALES VOLUME
  • 11.11.6 PRICING ANALYSIS
  • 11.11.7 SWOT ANALYSIS
  • 11.11.8 KEY STRATEGY
• 11.12 SPEC-CHEM INDUSTRY INC
  • 11.12.1 COMPANY OVERVIEW
  • 11.12.2 TYPES OFFERED
  • 11.12.3 PATENT DETAILS
  • 11.12.4 PRODUCTION CAPACITY
  • 11.12.5 SALES VOLUME
  • 11.12.6 PRICING ANALYSIS
  • 11.12.7 SWOT ANALYSIS
  • 11.12.8 KEY STRATEGY
• 11.13 AMBIOPHARM
  • 11.13.1 COMPANY OVERVIEW
  • 11.13.2 TYPES OFFERED
  • 11.13.3 PATENT DETAILS
  • 11.13.4 PRODUCTION CAPACITY
  • 11.13.5 SALES VOLUME
  • 11.13.6 PRICING ANALYSIS
  • 11.13.7 SWOT ANALYSIS
  • 11.13.8 KEY STRATEGY
• 11.14 LIPOTEC
  • 11.14.1 COMPANY OVERVIEW
  • 11.14.2 TYPES OFFERED
  • 11.14.3 PATENT DETAILS
  • 11.14.4 PRODUCTION CAPACITY
  • 11.14.5 SALES VOLUME
  • 11.14.6 PRICING ANALYSIS
  • 11.14.7 SWOT ANALYSIS
  • 11.14.8 KEY STRATEGY
• 11.15 USV PRIVATE LIMITED
  • 11.15.1 COMPANY OVERVIEW
  • 11.15.2 TYPES OFFERED
  • 11.15.3 PATENT DETAILS
  • 11.15.4 PRODUCTION CAPACITY
  • 11.15.5 SALES VOLUME
  • 11.15.6 PRICING ANALYSIS
  • 11.15.7 SWOT ANALYSIS
  • 11.15.8 KEY STRATEGY
• 11.16 CHEMISCHES LABORATORIUM DR. KURT RICHTER GMBH (CLR)
  • 11.16.1 COMPANY OVERVIEW
  • 11.16.2 TYPES OFFERED
  • 11.16.3 PATENT DETAILS
  • 11.16.4 PRODUCTION CAPACITY
  • 11.16.5 SALES VOLUME
  • 11.16.6 PRICING ANALYSIS
  • 11.16.7 SWOT ANALYSIS
  • 11.16.8 KEY STRATEGY
• 11.17 ACTIVE PEPTIDE COMPANY
  • 11.17.1 COMPANY OVERVIEW
  • 11.17.2 TYPES OFFERED
  • 11.17.3 PATENT DETAILS
  • 11.17.4 PRODUCTION CAPACITY
  • 11.17.5 SALES VOLUME
  • 11.17.6 PRICING ANALYSIS
  • 11.17.7 SWOT ANALYSIS
  • 11.17.8 KEY STRATEGY
• 11.18 SEIWA KASEI CO., LTD
  • 11.18.1 COMPANY OVERVIEW
  • 11.18.2 TYPES OFFERED
  • 11.18.3 PATENT DETAILS
  • 11.18.4 PRODUCTION CAPACITY
  • 11.18.5 SALES VOLUME
  • 11.18.6 PRICING ANALYSIS
  • 11.18.7 SWOT ANALYSIS
  • 11.18.8 KEY STRATEGY
• 11.19 RS SYNTHESIS
  • 11.19.1 COMPANY OVERVIEW
  • 11.19.2 TYPES OFFERED
  • 11.19.3 PATENT DETAILS
  • 11.19.4 PRODUCTION CAPACITY
  • 11.19.5 SALES VOLUME
  • 11.19.6 PRICING ANALYSIS
  • 11.19.7 SWOT ANALYSIS
  • 11.19.8 KEY STRATEGY
• 11.20 BCN PEPTIDES
  • 11.20.1 COMPANY OVERVIEW
  • 11.20.2 TYPES OFFERED
  • 11.20.3 PATENT DETAILS
  • 11.20.4 PRODUCTION CAPACITY
  • 11.20.5 SALES VOLUME
  • 11.20.6 PRICING ANALYSIS
  • 11.20.7 SWOT ANALYSIS
  • 11.20.8 KEY STRATEGY